Sun Life Financial Stock Drops Following Profit Forecast Update

Sun Life Financial’s stock took a significant hit, dropping 8.5% on Friday. This decline followed an announcement from Canadian insurers indicating they would miss the 2025 profit target for their U.S. dental business, mainly due to uncertainties surrounding Medicaid funding.

In 2022, Sun Life fortified its dental operations with a $2.5 billion acquisition of Dentaquest, but the company now anticipates net income from the dental segment to be below $100 million in 2025, particularly as it has faced challenges in the last quarter.

The revised forecast stems from unpredictable Medicaid funding, which the company indicated would hinder negotiations regarding compensation rates and claims across various states.

Sun Life collaborates with the U.S. to oversee dental benefits under Medicaid and Medicare Advantage through the Dentaquest division, heavily relying on government support.

CEO Kevin Strain noted in an interview that claims are rising more rapidly as people rush to use Medicaid benefits, fearing they might lose them. “So they’ll go to the dentist more quickly,” he explained.

Strain also mentioned that states seem hesitant to take on the increased costs for billing. “If we’re struggling, we can imagine that small players are really struggling with it… we’re going to work on how to get through it,” he added.

The U.S. remains one of Sun Life’s fastest-growing and capital-intensive markets, the report stated.

Looking ahead, Sun Life expects net profits to grow over 12% in the U.S. long-term, with the dental business projected to contribute at least a third to the region’s overall revenues.

Overall, shares have lost about 8% of their value, factoring in Thursday’s declines, while Pier Manulif, which has also reported some weakness in its U.S. operations, saw a drop of 6.5%.

National Bank Analyst Gabriel Decaine emphasized that the issues surrounding Sun Life’s U.S. dental business, which led to the company withdrawing its profit target for 2025, are likely to have repercussions beyond just this quarter.

Moreover, analysts are concerned that Sun Life’s dental segment might be impacted by provisions from U.S. President Donald Trump’s recent tax cuts and spending law aimed at curbing Medicaid spending. Restrictions on eligibility could potentially affect future growth by lowering Medicaid enrollments over time.

Underlying net income in the U.S. decreased by 4%, which comprises around 20% of the company’s overall revenue.